Selected article for: "docking score and original ligand"
Author: Wang, Xue-Jiao; Zhang, Jun; Wang, Shu-Qing; Xu, Wei-Ren; Cheng, Xian-Chao; Wang, Run-Ling
Title: Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone
  • Cord-id: uotug8ej
  • Document date: 2014_11_7
    • ID: uotug8ej
    Snippet: The thiazolidinedione class peroxisome proliferator-activated receptor gamma (PPARγ) agonists are restricted in clinical use as antidiabetic agents because of side effects such as edema, weight gain, and heart failure. The single and selective agonism of PPARγ is the main cause of these side effects. Multitargeted PPARα/γ/δ pan agonist development is the hot topic in the antidiabetic drug research field. In order to identify PPARα/γ/δ pan agonists, a compound database was established by
    Document: The thiazolidinedione class peroxisome proliferator-activated receptor gamma (PPARγ) agonists are restricted in clinical use as antidiabetic agents because of side effects such as edema, weight gain, and heart failure. The single and selective agonism of PPARγ is the main cause of these side effects. Multitargeted PPARα/γ/δ pan agonist development is the hot topic in the antidiabetic drug research field. In order to identify PPARα/γ/δ pan agonists, a compound database was established by core hopping of rosiglitazone, which was then docked into a PPARα/γ/δ active site to screen out a number of candidate compounds with a higher docking score and better interaction with the active site. Further, absorption, distribution, metabolism, excretion, and toxicity prediction was done to give eight compounds. Molecular dynamics simulation of the representative Cpd#1 showed more favorable binding conformation for PPARs receptor than the original ligand. Cpd#1 could act as a PPARα/γ/δ pan agonist for novel antidiabetic drug research.

    Search related documents:
    Co phrase search for related documents
    • active site and admet descriptors: 1, 2, 3
    • active site and admet module: 1
    • active site and admet prediction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • active site and admet prediction study: 1
    • active site and admet prediction technique: 1
    • active site and admet prediction technique docking: 1
    • active site and liver function: 1
    • active site and low density: 1
    • active site and low density lipoprotein: 1
    • liver function and low density: 1, 2, 3, 4, 5, 6, 7, 8
    • liver function and low density lipoprotein: 1, 2, 3, 4, 5, 6, 7